File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/cpf.12614
- Scopus: eid_2-s2.0-85076923584
- PMID: 31823430
- WOS: WOS:000503979600001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Relationship between plasma volume and essential blood constituents in patients with heart failure and preserved ejection fraction
Title | Relationship between plasma volume and essential blood constituents in patients with heart failure and preserved ejection fraction |
---|---|
Authors | |
Keywords | hemodilution erythropoietin electrolytes heart failure blood volume haemoglobin mass |
Issue Date | 2020 |
Citation | Clinical Physiology and Functional Imaging, 2020, v. 40, n. 2, p. 131-138 How to Cite? |
Abstract | © 2019 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd Introduction: Notwithstanding recent progress on molecular mechanisms underlying heart failure with preserved ejection fraction (HFpEF), multiple pathophysiological aspects of this condition including the basis of anaemia and other haematological disorders remain unresolved. In this study, we sought to determine the relationship of plasma volume (PV), a plausible confounding factor for the concentration of solutes in blood, with key haematological markers in HFpEF patients. Methods: Total circulating PV was determined with high precision, automated carbon monoxide rebreathing in 24 stable HFpEF patients (70 ± 8 years, left ventricular ejection fraction = 55±5%) and 18 healthy age- and sex-matched control (HC) individuals. Linear regression analyses were performed to determine the association of PV with a comprehensive set of haematological variables. Results: Haematocrit (40·1 ± 4·9 versus 43·6 ± 2·7%, P = 0·004) and haemoglobin concentration (131 ± 16 versus 142 ± 7 g l−1, P = 0·003) were reduced in HFpEF patients compared with HC individuals. In regression analyses, PV was negatively associated with haematocrit (r = −0·45, P = 0·029) and haemoglobin concentration (r = −0·44, P = 0·030) in HFpEF patients, whereas these variables were not associated with PV in HC individuals (P≥0·198). Regarding blood electrolytes, PV was negatively associated with K+ (r = −0·43, P = 0·036) and Ca2+ (r = −0·44, P = 0·032) in HFpEF patients but not in HC individuals (P≥0·734). None of the above associations were detected in HFpEF patients when using ideal instead of measured PV. Conclusion: The blood concentration of routine markers of anaemia and electrolyte balance is specifically and linearly associated with PV in HFpEF patients. Excess or deficit of circulating PV may confound clinical diagnosis in this population. |
Persistent Identifier | http://hdl.handle.net/10722/288778 |
ISSN | 2023 Impact Factor: 1.3 2023 SCImago Journal Rankings: 0.487 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Diaz-Canestro, Candela | - |
dc.contributor.author | Haider, Thomas | - |
dc.contributor.author | Lundby, Carsten | - |
dc.contributor.author | Montero, David | - |
dc.date.accessioned | 2020-10-12T08:05:51Z | - |
dc.date.available | 2020-10-12T08:05:51Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Clinical Physiology and Functional Imaging, 2020, v. 40, n. 2, p. 131-138 | - |
dc.identifier.issn | 1475-0961 | - |
dc.identifier.uri | http://hdl.handle.net/10722/288778 | - |
dc.description.abstract | © 2019 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd Introduction: Notwithstanding recent progress on molecular mechanisms underlying heart failure with preserved ejection fraction (HFpEF), multiple pathophysiological aspects of this condition including the basis of anaemia and other haematological disorders remain unresolved. In this study, we sought to determine the relationship of plasma volume (PV), a plausible confounding factor for the concentration of solutes in blood, with key haematological markers in HFpEF patients. Methods: Total circulating PV was determined with high precision, automated carbon monoxide rebreathing in 24 stable HFpEF patients (70 ± 8 years, left ventricular ejection fraction = 55±5%) and 18 healthy age- and sex-matched control (HC) individuals. Linear regression analyses were performed to determine the association of PV with a comprehensive set of haematological variables. Results: Haematocrit (40·1 ± 4·9 versus 43·6 ± 2·7%, P = 0·004) and haemoglobin concentration (131 ± 16 versus 142 ± 7 g l−1, P = 0·003) were reduced in HFpEF patients compared with HC individuals. In regression analyses, PV was negatively associated with haematocrit (r = −0·45, P = 0·029) and haemoglobin concentration (r = −0·44, P = 0·030) in HFpEF patients, whereas these variables were not associated with PV in HC individuals (P≥0·198). Regarding blood electrolytes, PV was negatively associated with K+ (r = −0·43, P = 0·036) and Ca2+ (r = −0·44, P = 0·032) in HFpEF patients but not in HC individuals (P≥0·734). None of the above associations were detected in HFpEF patients when using ideal instead of measured PV. Conclusion: The blood concentration of routine markers of anaemia and electrolyte balance is specifically and linearly associated with PV in HFpEF patients. Excess or deficit of circulating PV may confound clinical diagnosis in this population. | - |
dc.language | eng | - |
dc.relation.ispartof | Clinical Physiology and Functional Imaging | - |
dc.subject | hemodilution | - |
dc.subject | erythropoietin | - |
dc.subject | electrolytes | - |
dc.subject | heart failure | - |
dc.subject | blood volume | - |
dc.subject | haemoglobin mass | - |
dc.title | Relationship between plasma volume and essential blood constituents in patients with heart failure and preserved ejection fraction | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/cpf.12614 | - |
dc.identifier.pmid | 31823430 | - |
dc.identifier.scopus | eid_2-s2.0-85076923584 | - |
dc.identifier.volume | 40 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 131 | - |
dc.identifier.epage | 138 | - |
dc.identifier.eissn | 1475-097X | - |
dc.identifier.isi | WOS:000503979600001 | - |
dc.identifier.issnl | 1475-0961 | - |